Bayer Looks To Quick Release Crystals To Shine Light On Aspirin Brand
This article was originally published in The Tan Sheet
Executive Summary
As private label OTCs threaten brand name stalwarts in the deepening economic recession, Bayer hopes to galvanize its iconic aspirin line with a powdered delivery format in single-dose pouches